Mode
Text Size
Log in / Sign up

Systematic review finds immune markers IL-1β and TNF-α associated with negative symptoms in first episode psychosisInflammation Linked to Low Energy in Early Psychosis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that IL-1β and TNF-α show reproducible associations with negative symptoms in first episode psychosis, though evidence remains observational.

This systematic review analyzed 7 case-control studies comparing peripheral blood immune markers in individuals with first episode psychosis (FEP) against healthy controls. The primary outcome was the association between these immune markers and negative symptoms, with secondary outcomes including negative symptom severity and inflammatory marker levels. Follow-up duration was not reported.

FEP individuals generally showed elevated levels of inflammatory markers compared with controls, though specific effect sizes and absolute numbers were not reported. Modest but consistently positive associations were found between immune markers and negative symptom severity. Among cytokines, IL-1β and TNF-α demonstrated the most reproducible associations with negative symptom severity, while findings for other cytokines were more variable.

Safety and tolerability data were not reported. Key limitations include heterogeneity in immune measurement methods and symptom assessment approaches, with most studies relying on total negative symptom scores rather than examining symptom subdomains or dimensional constructs. Funding and conflicts of interest were not reported.

For clinical practice, these findings suggest peripheral immune dysregulation, particularly involving IL-1β and TNF-α, may be associated with negative symptom severity in FEP. However, the evidence remains observational with significant heterogeneity, limiting mechanistic interpretation. Future studies should prioritize dimensional assessment of negative symptoms, stratification by inflammatory profiles, and integration of cellular immune phenotyping.

Many people with a first episode of psychosis feel empty inside. They struggle to feel pleasure, keep friends, or get out of bed. Doctors call this "negative symptoms." It is not just sadness. It is a real loss of drive and connection.

These symptoms often start right at the beginning of the illness. They make recovery much harder than positive symptoms like hearing voices. Current treatments focus on stopping hallucinations. But they do little for the low energy and lack of motivation.

The surprising shift

For years, scientists thought these symptoms were just part of the brain's wiring. But new clues point to the immune system. Think of your body as a city. The immune system is the police force. Sometimes, this force gets too active or confused. This causes a low-grade fire in the body.

What scientists didn't expect

Researchers looked at blood samples from young adults with their first episode of psychosis. They compared these samples to healthy people. They found that the "police force" was indeed more active in the patients. Specifically, two markers called IL-1β and TNF-α were higher. These are like smoke detectors that go off when there is trouble.

Imagine your brain is a busy office. The immune markers are like loud construction noises coming from outside. When these noises are too loud, the workers in the office cannot focus. They feel tired and unmotivated. This is similar to what happens in the brain. The inflammation acts like a fog that blocks the ability to feel good or want to do things.

The team searched for studies published in the last five years. They looked at seven different research projects. Most participants were young adults who had never taken antipsychotic drugs before. This is important because it shows the link exists before heavy medication starts.

The results were clear but not perfect. People with psychosis had higher levels of inflammation than healthy controls. The link between inflammation and negative symptoms was consistent across studies. However, the connection was not super strong. It was a modest link, but it was there.

But there's a catch.

Most studies only looked at the total score of negative symptoms. They did not break the symptoms down into smaller parts. This makes it hard to know exactly which immune marker causes which specific feeling.

This research fits into a bigger picture. We know that stress and infection can worsen mental health. This study suggests that the body's response to stress might be the root cause of the low energy. It changes how we view the illness. It is not just a chemical imbalance in the brain. It is also a whole-body issue.

If you or a loved one is struggling with low energy, talk to a doctor. Knowing about inflammation does not mean you need a new drug today. It means doctors might look at lifestyle factors. Sleep, diet, and exercise can lower inflammation. These steps might help improve mood and drive.

The study has some limits. The link is not perfect. Different labs measure inflammation in different ways. Also, most studies used total scores instead of detailed breakdowns. This means we do not fully understand the exact mechanism yet.

Scientists will need to do more work. They will try to measure inflammation in more detail. They will also look at different types of immune cells. This research could lead to new treatments in the future. Until then, managing overall health remains the best first step.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BackgroundNegative symptoms are a core feature of psychotic disorders, evident from the first episode of psychosis (FEP), and are strongly associated with poor functional outcomes. Increasing evidence suggests that immune dysregulation may contribute to negative symptom expression in FEP individuals; however, findings remain heterogeneous. This systematic review aimed to synthesise recent evidence on the association between peripheral blood immune markers and negative symptoms in FEP.MethodsA systematic search of PubMed and Scopus was conducted following PRISMA guidelines. Observational studies published within the last five years were included if they assessed peripheral blood immune markers and negative symptoms in individuals with FEP and included a healthy control group. Study quality was evaluated using the Newcastle-Ottawa Scale. Findings were synthesised narratively due to methodological heterogeneity.ResultsSeven case-control studies met the inclusion criteria, comprising predominantly young adults with FEP, including both antipsychotic-naïve and minimally treated individuals. Across studies, a broad range of immune markers was assessed, most commonly IL-6, IL-1β, and TNF-α. FEP individuals generally showed elevated levels of inflammatory markers compared with controls. Associations between immune markers and negative symptoms were modest but consistently positive, with IL-1β and TNF-α showing the most reproducible associations with negative symptom severity. Findings for other cytokines were more variable. Notably, most studies relied on total negative symptom scores, and none examined symptom subdomains or dimensional constructs.ConclusionsPeripheral immune dysregulation, particularly involving IL-1β and TNF-α, appears to be associated with negative symptom severity in FEP. However, heterogeneity in immune measurement and symptom assessment limits mechanistic interpretation. Future studies should prioritise dimensional assessment of negative symptoms, stratification by inflammatory profiles, and integration of cellular immune phenotyping to better elucidate immune-symptom relationships in early psychosis.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.